FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
102 hedge funds and large institutions have $728M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 27 increasing their positions, 34 reducing their positions, and 42 closing their positions.
29% more capital invested
Capital invested by funds: $566M → $728M (+$162M)
11% less funds holding
Funds holding: 114 → 102 (-12)
21% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 34
29% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 42
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
86% less call options, than puts
Call options by funds: $21.4M | Put options by funds: $151M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$76.8M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$72M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$69.6M |
| 4 |
Morgan Stanley
New York
|
+$47.4M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$37.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$78.4M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$59.1M |
| 3 |
Millennium Management
New York
|
-$36.9M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$31.7M |
| 5 |
RA
Royce & Associates
New York
|
-$30.9M |
FURX Hedge Fund Activity: Q2 2014 in Review
102 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q2 2014, worth a combined $728M — up 29% from $566M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of FURX and 30 opened new positions — a net loss of 12 holders — while 34 trimmed existing stakes and 27 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $76.8M. The largest seller was Artal Group, exiting entirely with an estimated $78.4M sold.
- 102 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q2 2014, down from 114 in Q1 2014.
- Funds reported $728M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2014, up 29% quarter-over-quarter.
- 30 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2014 and 42 closed out, a net change of -12 holders.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2014 was D.E. Shaw & Co, an estimated $76.8M added.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2014 was Artal Group, an estimated $78.4M sold.
Based on aggregated 13F filings for Q2 2014.